mAbs Archives - EpiVax

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies

by Elena Iemma | Apr 1, 2024

Design, development and characterization of ACT017, a humanized Fab that blocks platelet’s glycoprotein VI function without causing bleeding risks.

by Sarah Moniz | Apr 10, 2018

Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies.

by Sarah Moniz | Apr 10, 2018

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

by Adam | Oct 22, 2016

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor. Adnexus MAbs. 2011 [ISPRI prediction of immunogenicity]

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies

Design, development and characterization of ACT017, a humanized Fab that blocks platelet’s glycoprotein VI function without causing bleeding risks.

Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies.

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

Recent Posts

Recent Comments